Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1966-7-31
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0001-6268
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
441-56
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:5882616-Astrocytoma,
pubmed-meshheading:5882616-Blood-Brain Barrier,
pubmed-meshheading:5882616-Brain Neoplasms,
pubmed-meshheading:5882616-Cyclophosphamide,
pubmed-meshheading:5882616-Glioma,
pubmed-meshheading:5882616-Humans,
pubmed-meshheading:5882616-Meningioma,
pubmed-meshheading:5882616-Neurilemmoma,
pubmed-meshheading:5882616-Oligodendroglioma
|
pubmed:year |
1965
|
pubmed:articleTitle |
[Tracer studies with radioactive-labelled cyclophosphamide in brain tumors].
|
pubmed:publicationType |
Journal Article
|